甲福明通过氧化,AMPK,通道和PKC来放松大鼠胸前大动脉
1Bursa Uludag University Medicine School, Physiology Department, Bursa, Turkey.
Iranian journal of basic medical sciences
|August 22, 2023
概括
梅特福林通过激活通道和内皮依赖通道,有效地放松大鼠胸前大动脉. 这种血管松涉及AMPK,eNOS/NO/sGS,PVAT和PKC信号,突出显示了甲胺对心血管的影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管生理学心血管生理学
- 分子生物学分子生物学
背景情况:
- 甲胺是一种广泛使用的抗糖尿病药物.
- 它对血管功能,特别是胸前大动脉的影响需要进一步阐明.
- 了解这些机制可以揭示新的治疗点.
研究的目的:
- 为了研究甲胺对大鼠胸前动脉的功能作用.
- 为了确定甲胺诱导的血管松的潜在分子机制.
主要方法:
- 使用来自Wistar Albino大鼠的隔离胸前大动脉片段.
- 血管段被用化或烯合并.
- 应用了累积度的甲福明,有或没有信号通路和通道的抑制剂.
主要成果:
- 甲福明显示出强大的度依赖性血管松作用.
- 切除内皮细胞显著降低了甲福林的效果.
- 周血管脂肪组织增强了血管松作用.
- 抑制AMPK,eNOS/NO/sGS,PKC和各种通道 (BKCa,IKCa,Kv,Kir,K2p) 的抑制剂减弱了甲胺的作用.
结论:
- 甲胺诱导大鼠胸前大动脉显著的血管松.
- 机制涉及多个通道亚型和内皮依赖的通路.
- 涉及AMP激活蛋白激酶 (AMPK),内皮氧化合成酶 (eNOS) /氧化 (NO) /可溶性酸环酶 (sGC) 信号传导,周周脂肪组织 (PVAT) 和蛋白激酶C (PKC) 途径.
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Antihypertensive Drugs: Action of Calcium Channel Blockers
567
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
567
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230
Antihypertensive Drugs: Vasodilators
566
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
566
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K


